Paliperidon udskilles i brystmælk i et sådant omfang, at terapeutiske doser med sandsynlighed vil påvirke det ammede barn.
Paliperidone is excreted in the breast milk to such an extent that effects on the breast-fed infant are likely if therapeutic doses are administered to breast-feeding women.